Menu

Circulating tumor cells in lung carcinogenesis: minireview

  • Free access
  • Editor's choice

Henrieta Škovierová, Eva Vidomanová, Miroslav Škoviera, Barbara Tóthová, Erika Halašová,  Ján Strnádel

Abstract:

Metastasis development causes death in over 90% of cancer patients, and understanding the underlying biological features has long been hindered by difficulties in studying the widespread cancerous lesions and the absence of reliable methods of isolating and detecting viable metastatic cells during disease progression. These problems have an adverse impact on developing new agents capable of blocking cancer spread. Circulating tumor cells (CTCs) have a crucial role in carcinogenesis, and this review presents advanced understanding of the characteristics of CTCs and CTC cluster metastatic properties. CTC analysis could well be more valuable for the biomarker profile than tissue biopsies, and herein we highlight current research findings which have the potential to improve clinical management of lung cancer patients. We also discuss problems in CTCs and CTC cluster biology, the limitations of detection methods and possible future diagnostic and therapeutic approaches for the study of circulating cells.

Received date: 04/30/2018

Accepted date: 06/13/2018

Ahead of print publish date: 08/10/2018

Issue: 1/2019

Volume: 66

Pages: 1 — 7

Keywords: circulating tumor cells (CTCs), CTC clusters, lung cancer, metastases

DOI: 10.4149/neo_2018_180430N281

Pubmed

Shopping cart is empty